FDA Adverse Event Injury Summary report: N

WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM

MDR report key: 16912090 · Received May 11, 2023

Report

Report Number
2124215-2023-19396
Event Type
Injury
Date Received
May 11, 2023
Date of Event
April 20, 2023
Report Date
June 29, 2023
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NGV
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

B3: DATE OF EVENT - AWARE DATE OF 20APR2023 USED AS EVENT DATE IS UNKNOWN. IMPLANTING FACILITY: (B)(6).

Additional Manufacturer Narrative · 0

B3: DATE OF EVENT - AWARE DATE OF (B)(6) 2023 USED AS EVENT DATE IS UNKNOWN.

Description of Event or Problem · 0

THE FOLLOWING EVENT ORIGINATED FROM SOCIAL MEDIA, AND THEREFORE DESPITE GOOD FAITH EFFORTS THE INFORMATION IS OFTEN INCOMPLETE. ADDITIONALLY, DUE TO THE LIMITED INFORMATION RECEIVED THROUGH GOOD FAITH EFFORTS, THIS EVENT MAY REPRESENT A DUPLICATE OF AN EVENT WHICH WAS ALREADY KNOWN TO BOSTON SCIENTIFIC AND REPORTED AS A MEDICAL DEVICE REPORT WHEN THE EVENT OCCURRED. IT WAS REPORTED VIA SOCIAL MEDIA THAT A DEVICE LEAK OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS PERFORMED USING A WATCHMAN FLX LAA CLOSURE DEVICE WITH DELIVERY SYSTEM (WDS). AT AN UNSPECIFIED TIME PERI OR POST PROCEDURALLY, A DEVICE LEAK WAS IDENTIFIED. THE PATIENT REPORTED PERSISTENT FATIGUE AND DIZZINESS AND WAS INSTRUCTED TO CONTINUE TAKING CLOPIDOGREL.

Description of Event or Problem · 0

THE FOLLOWING EVENT ORIGINATED FROM SOCIAL MEDIA, AND THEREFORE DESPITE GOOD FAITH EFFORTS THE INFORMATION IS OFTEN INCOMPLETE. ADDITIONALLY, DUE TO THE LIMITED INFORMATION RECEIVED THROUGH GOOD FAITH EFFORTS, THIS EVENT MAY REPRESENT A DUPLICATE OF AN EVENT WHICH WAS ALREADY KNOWN TO BOSTON SCIENTIFIC AND REPORTED AS A MEDICAL DEVICE REPORT WHEN THE EVENT OCCURRED. IT WAS REPORTED VIA SOCIAL MEDIA THAT A DEVICE LEAK OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS PERFORMED USING A WATCHMAN FLX LAA CLOSURE DEVICE WITH DELIVERY SYSTEM (WDS). AT AN UNSPECIFIED TIME PERI OR POST PROCEDURALLY, A DEVICE LEAK WAS IDENTIFIED. THE PATIENT REPORTED PERSISTENT FATIGUE AND DIZZINESS AND WAS INSTRUCTED TO CONTINUE TAKING CLOPIDOGREL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1351248 WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL NGV BOSTON SCIENTIFIC CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 Male Other